Prosperitas Financial LLC Merck & Co., Inc. Transaction History

Prosperitas Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$111.15 - $128.97 $224,967 - $261,035	-2,024 Closed	0 $0
Q2 2024 Oct 29, 2024	BUY	$123.8 - $132.96 $250,571 - $269,111	2,024 New	2,024 $251 Million
Q1 2024 May 09, 2024	BUY	$113.24 - $131.95 $339 - $395	3 Added 0.15%	2,022 $267 Million
Q4 2023 Jan 30, 2024	SELL	$100.18 - $109.02 $41,073 - $44,698	-410 Reduced 16.88%	2,019 $220 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $250,065 - $277,707	2,429 New	2,429 $250 Million

3,808

1.92B

13.4M

10.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Prosperitas Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Prosperitas Financial LLC with notifications on news.